Delivery Order SPE2DB22D3501-SPE2DB24FWQ07
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,939.44 firm fixed price delivery order is for the supply of fluticasone-salmeterol 115-21 12GM, a combination medication used for the treatment of asthma and COPD. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a $5,384.82 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fluticasone-salmeterol, a combination medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of March 27, 2025 and is a firm fixed-price arrangement. The contract is not designated as a set-aside....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.06 delivery order is for the supply of Fluticasone-Salmeterol 45-21 12GM, a medication used in the treatment of respiratory conditions. The contract has an ultimate completion date of October 17, 2024 and is a Firm Fixed Price agreement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,475.42 contract is for the delivery of fluticasone-salmeterol 115-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of April 11, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a $5,273.63 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of a pharmaceutical product, Fluticasone-Salmeterol 115-21 12GM. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including prescription drugs and medical...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,372.95 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,564,590,859 units of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This is a $5,414.15 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,135.65 firm-fixed-price delivery order is for the supply of fluticasone-salmeterol 115-21 12GM, a combination medication used for the treatment of asthma and chronic obstructive pulmonary disease. The contract does not have a set-aside designation, indicating open competition. It is part of a larger $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $5,454.01 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a prescription medication product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities to support...
The U.S. Defense Logistics Agency (DLA) awarded a $7,648.67 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of Fluticasone-Salmeterol 115-21 12GM pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 between Amerisourcebergen and DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of essential...